Canada's Final User-Fee Schedule To Include Three Fee-Reduction Provisions
This article was originally published in The Gray Sheet
Executive Summary
Final user-fee regulations aimed at recouping the cost of implementing and maintaining Canada's revised medical device regulatory framework are tentatively scheduled for publication in June in the Canada Gazette Part II pending final approval by the Canadian Health Ministry and Treasury Board.
You may also be interested in...
RAPS In Brief
PMA ABCs: Action definitions and procedures guidance will explain terms related to all PMA decisions listed under the performance goals of MDUFMA, ranging from "approval" and "approvable pending GMP" to "denial" and "abandonment," CDRH Premarket Approval Section Director Thinh Nguyen reports at the Regulatory Affairs Professionals Society medical device conference in San Francisco March 4. One of six PMA-related guidances under development, the document will provide criteria for decision letters and explain how certain actions affect FDA's review clock and performance goals...
RAPS In Brief
PMA ABCs: Action definitions and procedures guidance will explain terms related to all PMA decisions listed under the performance goals of MDUFMA, ranging from "approval" and "approvable pending GMP" to "denial" and "abandonment," CDRH Premarket Approval Section Director Thinh Nguyen reports at the Regulatory Affairs Professionals Society medical device conference in San Francisco March 4. One of six PMA-related guidances under development, the document will provide criteria for decision letters and explain how certain actions affect FDA's review clock and performance goals...
Canada Seeking Input On Consensus Standard Recognition Draft Policy
Priority review of recognized medical device consensus standards by Canada's Therapeutic Products Programme (TPP) will be given to those addressing issues germane to several types of devices, according to the draft Policy on Recognition and Use of Standards under Canada's Medical Devices Regulation.